Biophysical analysis of progressive C-terminal truncations of human apolipoprotein E4: insights into secondary structure and unfolding properties.
暂无分享,去创建一个
[1] M. Nieminen,et al. Apolipoprotein E polymorphism is associated with both carotid and coronary atherosclerosis in patients with coronary artery disease. , 2008, Nutrition, metabolism, and cardiovascular diseases : NMCD.
[2] H. Saito,et al. Contributions of the carboxyl-terminal helical segment to the self-association and lipoprotein preferences of human apolipoprotein E3 and E4 isoforms. , 2008, Biochemistry.
[3] Radiya M. Sojitrawala,et al. A monomeric, biologically active, full-length human apolipoprotein E. , 2007, Biochemistry.
[4] K. Weisgraber,et al. Apolipoprotein E•dipalmitoylphosphatidylcholine particles are ellipsoidal in solutions⃞ Published, JLR Papers in Press, February 17, 2007. , 2007, Journal of Lipid Research.
[5] T. Forte,et al. The C-terminal lipid-binding domain of apolipoprotein E is a highly efficient mediator of ABCA1-dependent cholesterol efflux that promotes the assembly of high-density lipoproteins. , 2007, Biochemistry.
[6] K. Weisgraber,et al. Apolipoprotein E structure: insights into function. , 2006, Trends in biochemical sciences.
[7] R. Mahley,et al. Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[8] H. Saito,et al. Effect of carboxyl-terminal truncation on structure and lipid interaction of human apolipoprotein E4. , 2006, Biochemistry.
[9] K. Weisgraber,et al. Model of Biologically Active Apolipoprotein E Bound to Dipalmitoylphosphatidylcholine* , 2006, Journal of Biological Chemistry.
[10] R. Mahley,et al. Lipid- and receptor-binding regions of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicity. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[11] M. Krieger,et al. SR-BI mediates cholesterol efflux via its interactions with lipid-bound ApoE. Structural mutations in SR-BI diminish cholesterol efflux. , 2005, Biochemistry.
[12] C. Adessi,et al. A 13 kDa carboxy‐terminal fragment of ApoE stabilizes Abeta hexamers , 2005, Journal of neurochemistry.
[13] Meir J Stampfer,et al. Meta-Analysis: Apolipoprotein E Genotypes and Risk for Coronary Heart Disease , 2004, Annals of Internal Medicine.
[14] D. Kardassis,et al. Probing the pathways of chylomicron and HDL metabolism using adenovirus-mediated gene transfer , 2004, Current opinion in lipidology.
[15] Tony Wyss-Coray,et al. Neuron-Specific Apolipoprotein E4 Proteolysis Is Associated with Increased Tau Phosphorylation in Brains of Transgenic Mice , 2004, The Journal of Neuroscience.
[16] K. Weisgraber,et al. Effects of Polymorphism on the Lipid Interaction of Human Apolipoprotein E* , 2003, Journal of Biological Chemistry.
[17] V. Zannis,et al. Domains of apoE required for binding to apoE receptor 2 and to phospholipids: implications for the functions of apoE in the brain. , 2003, Biochemistry.
[18] L. Mucke,et al. Carboxyl-terminal-truncated apolipoprotein E4 causes Alzheimer's disease-like neurodegeneration and behavioral deficits in transgenic mice , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[19] K. Weisgraber,et al. Influence of apoE domain structure and polymorphism on the kinetics of phospholipid vesicle solubilization DOI 10.1194/jlr.M200157-JLR200 , 2002, Journal of Lipid Research.
[20] K. Weisgraber,et al. Comparison of the stabilities and unfolding pathways of human apolipoprotein E isoforms by differential scanning calorimetry and circular dichroism. , 2002, Biochimica et biophysica acta.
[21] M. Krieger,et al. Reconstituted Discoidal ApoE-Phospholipid Particles Are Ligands for the Scavenger Receptor BI , 2002, The Journal of Biological Chemistry.
[22] R. Mahley,et al. Apolipoprotein E fragments present in Alzheimer's disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[23] P. Weers,et al. Modulation of the lipid binding properties of the N-terminal domain of human apolipoprotein E3. , 2001, European journal of biochemistry.
[24] L. Havekes,et al. The amino-terminal 1-185 domain of apoE promotes the clearance of lipoprotein remnants in vivo. The carboxy-terminal domain is required for induction of hyperlipidemia in normal and apoE-deficient mice. , 2001, Biochemistry.
[25] K. V. van Dijk,et al. Domains of Apolipoprotein E Contributing to Triglyceride and Cholesterol Homeostasis in Vivo , 2001, The Journal of Biological Chemistry.
[26] H. Brewer,et al. Apolipoprotein specificity for lipid efflux by the human ABCAI transporter. , 2001, Biochemical and biophysical research communications.
[27] B. Rupp,et al. Differences in stability among the human apolipoprotein E isoforms determined by the amino-terminal domain. , 2000, Biochemistry.
[28] J. Hoeg,et al. Lipoproteins and atherogenesis. , 1998, Endocrinology and metabolism clinics of North America.
[29] E. Matsubara,et al. Isoform‐Specific Effects of Apolipoproteins E2, E3, and E4 on Cerebral Capillary Sequestration and Blood‐Brain Barrier Transport of Circulating Alzheimer's Amyloid β , 1997, Journal of neurochemistry.
[30] D. Agard,et al. Human apolipoprotein E. Role of arginine 61 in mediating the lipoprotein preferences of the E3 and E4 isoforms. , 1994 .
[31] D. Agard,et al. Salt bridge relay triggers defective LDL receptor binding by a mutant apolipoprotein. , 1994, Structure.
[32] J. Haines,et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.
[33] D. Atkinson,et al. Conformational analysis of apolipoprotein A-I and E-3 based on primary sequence and circular dichroism. , 1992, Biophysical journal.
[34] G. Anantharamaiah,et al. The amphipathic helix in the exchangeable apolipoproteins: a review of secondary structure and function. , 1992, Journal of lipid research.
[35] D A Agard,et al. Three-dimensional structure of the LDL receptor-binding domain of human apolipoprotein E. , 1991, Science.
[36] M. Krieger,et al. Expression of ApoE gene in Chinese hamster cells with a reversible defect in O-glycosylation. Glycosylation is not required for apoE secretion. , 1989, The Journal of biological chemistry.
[37] J. Taylor,et al. Glycosylation of human apolipoprotein E. The carbohydrate attachment site is threonine 194. , 1989, The Journal of biological chemistry.
[38] K. Weisgraber,et al. Human apolipoprotein E3 in aqueous solution. I. Evidence for two structural domains. , 1988, The Journal of biological chemistry.
[39] K. Weisgraber,et al. Human apolipoprotein E3 in aqueous solution. II. Properties of the amino- and carboxyl-terminal domains. , 1988, The Journal of biological chemistry.
[40] R J Havel,et al. Proposed nomenclature of apoE isoproteins, apoE genotypes, and phenotypes. , 1982, Journal of lipid research.
[41] A. Gotto,et al. Interaction of an apolipoprotein (apoLP-alanine) with phosphatidylcholine. , 1973, Biochemistry.
[42] G. Fasman,et al. Computed circular dichroism spectra for the evaluation of protein conformation. , 1969, Biochemistry.
[43] M. Shiao,et al. Structural variation in human apolipoprotein E3 and E4: secondary structure, tertiary structure, and size distribution. , 2005, Biophysical journal.
[44] K. Weisgraber,et al. Apolipoprotein E4 Forms a Molten Globule A POTENTIAL BASIS FOR ITS ASSOCIATION WITH DISEASE* , 2002 .
[45] J. Breslow,et al. Human apolipoprotein E isoprotein subclasses are genetically determined. , 1981, American journal of human genetics.